Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Eftathios Kastritis, Ioannis Papassotiriou, PhD, Maria Roussou, MD, Maria Gavriatopoulou, MD, Mantzou Aimilia, PhD, Erasmia Psimenou, MD, Smaragdi Marinaki, Charikleia Gakiopoulou, MD, Alexandra Margeli, PhD, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Gerasimos-Petros Papassotiriou, PhD, Aristea-Maria Papanota, MD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 3126.

https://doi.org/10.1182/blood-2019-125305

Published: 2019

Journal Articles

Altered Iron Parameters and Hepcidin Levels in a General Population: Lessons from the CHRIS Study

Fabiana Busti, MD PhD, Annalisa Castagna, B.S., PhD, Giacomo Marchi, MD, Oliviero Olivieri, MD, Peter Pramstaller, MD, Domenico Girelli, MD, PhD

Blood (2019) 134 (Supplement_1): 2239.

https://doi.org/10.1182/blood-2019-127098

Published: 2019

Journal Articles

Hepcidin, Soluble Transferrin Receptor, and Other Biomarkers of Iron Status Distributions in Healthy 2 Years Old Infants from a National Ambulatory Study in France

Anne-Sylvia Sacri, MD PhD, Thibaud Lefebvre, Pharm D.,PhD, Mariane De Montalembert, MD, Alain Bocquet, MD, Piotr Gembara, MD, Brigitte Pinçant, MD, Serge Hercberg, MD, PhD, Corinne Levy, MD, Amandine Ganon, Pharm D., Laurent Gouya, MD, PhD, Martin Chalumeau, MD, PhD

Blood (2019) 134 (Supplement_1): 4809.

https://doi.org/10.1182/blood-2019-128982

Published: 2019

Journal Articles

Pathological Hepatic Contrast-Enhanced Ultrasound (CEUS) Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation (allo-SCT)

Corinna Trenker, MD, Andreas Burchert, MD, Christian Sebastian Michel, MD, Caren Schuhmacher, Student, Jonas A. Schäfer, MD, Marius Dohse, MD, Andreas Neubauer, MD, Kristina Sohlbach, MD, Christian Görg, MD

Blood (2018) 132 (Supplement 1): 3359.

https://doi.org/10.1182/blood-2018-99-110479

Published: 2018

Journal Articles

Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NFkB Activation in Preclinical Patient-Derived Models of CNS Lymphoma

Huimin Geng, PhD, Brice Tiret, PhD, Hua-Xin Gao, PhD, Cigall Kadoch, PhD, Ming Lu, PhD, Lingjing Chen, PhD, Ilwoo Park, PhD, Gerd Melkus, PhD, Adam Elkhaled, PhD, John Kurhanewicz, PhD, Lisa Drew, PhD, Sebastien Degorce, PhD, Michele Mayo, PhD, Keith Dillman, PhD, Rana Anjum, PhD, Andrew Bloecher, PhD, Myriam Chaumeil, PhD, James Rubenstein, MD, PhD

Blood (2018) 132 (Supplement 1): 2840.

https://doi.org/10.1182/blood-2018-99-117625

Published: 2018

Journal Articles

A Novel RAD51 Inhibitor, CYT01B, Shows Anti-Cancer Activity in Preclinical Models of Aid Expressing Lymphomas

Muneer G Hasham, PhD, Darryl Patrick, Leanne Bedard, Joseph Vacca, Casey McComas, Alfredo Castro, Melinda Day, PhD, Kevin Mills, PhD

Blood (2018) 132 (Supplement 1): 2944.

https://doi.org/10.1182/blood-2018-99-119351

Published: 2018

Journal Articles

Molecular Quantification of Tissue Mast Cell Burden in Systemic Mastocytosis: A New Approach for Diagnostics and Prognostication

Greiner Georg, MD PhD, Michael Gurbisz, MSc, Franz Ratzinger, MD, Nadine Witzeneder, MSc, Svenja-Verena Class, Ingrid Simonitsch-Klupp, MD, Harald Esterbauer, MD PhD, Matthias Mayerhofer, MD, Wolfgang R. Sperr, Leonhard Muellauer, MD PhD, Peter Valent, Gregor Hoermann

Blood (2018) 132 (Supplement 1): 3043.

https://doi.org/10.1182/blood-2018-99-116492

Published: 2018

Journal Articles

New Blood Based M-Protein Quantification Method 3,000 Times More Sensitive Than Standard SPEP

Zac McDonald, PhD, Qixin Liu, Paul Taylor, Liqiang Yang, PhD, Bin Ma, PhD

Blood (2018) 132 (Supplement 1): 1905.

https://doi.org/10.1182/blood-2018-99-114907

Published: 2018

Journal Articles

Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Ahmet Yalcinkaya, MD, Selma Unal, MD, Yesim Oztas, MD PhD

Blood (2017) 130 (Supplement 1): 2240.

https://doi.org/10.1182/blood.V130.Suppl_1.2240.2240

Published: 2017

Journal Articles

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Jonathan Ko, Christian Breunig, Vianiuhini Figueroa, Nicola Lehners, MD, Anja Baumann, Aniko Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Hartmut Goldschmidt, MD, Andreas Pahl, Marc S Raab, MD PhD

Blood (2017) 130 (Supplement 1): 3070.

https://doi.org/10.1182/blood.V130.Suppl_1.3070.3070

Published: 2017

Journal Articles

Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study

Heinz Ludwig, MD, Andrew Spencer, MD, Tibor Kovacsovics, Nashat Y. Gabrail, Leonard Minuk, Amy S. Kimball, Robert J. Pelham, Ying C. Ou, Robert Z. Orlowski, MD PhD

Blood (2017) 130 (Supplement 1): 3125.

https://doi.org/10.1182/blood.V130.Suppl_1.3125.3125

Published: 2017

Journal Articles

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

Tadeusz Robak, Isidro Jarque, Vasile Musteata, Peter Kiessling, Ute Massow, James Higginson, Rose Snipes, Stephen Jolles

Blood (2017) 130 (Supplement 1): 15.

https://doi.org/10.1182/blood.V130.Suppl_1.15.15

Published: 2017

Journal Articles

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Kah-Whye Peng, PhD, Linh Pham, Lianwen Zhang, PhD, Rebecca Nace, Nathan Jenks, Michael Steele, Alysha Newsom, Ronald Marler, DVM, PhD, Martha Q Lacy, MD, Stephen J. Russell, MD PhD

Blood (2017) 130 (Supplement 1): 1807.

https://doi.org/10.1182/blood.V130.Suppl_1.1807.1807

Published: 2017

Journal Articles

Evaluating Pembrolizumab Interference with Monoclonal Protein Detection By Immunofixation and By MALDI-TOF Mass Spectrometry (MASS-FIX)

Taxiarchis Kourelis, MD, David L. Murray, MDPhD, Angela Dispenzieri, MD, Jody L. Frinack, B.S., Melea D. Hetrick, B.S., Maria Alice V. Willrich, PhD

Blood (2017) 130 (Supplement 1): 4428.

https://doi.org/10.1182/blood.V130.Suppl_1.4428.4428

Published: 2017

Journal Articles

Hemophilia a Clots Generated with Recombinant Factor VIIa Differed in Structure and Composition from Those Formed with Factor VIII

Lilley Leong, Irina N. Chernysh, Yifan Xu, Cornell Mallari, Billy Wong, Derek Sim, Adam Cuker, MD MS, Joseph Marturano, Thomas Lowery, Katalin Kauser, John W. Weisel

Blood (2016) 128 (22): 3798.

https://doi.org/10.1182/blood.V128.22.3798.3798

Published: 2016

Journal Articles

Quantification of Erythroblast- and Myelocyte-Derived mRNAs in Plasma Exosomes As an Indicator of Bone Marrow Status in Patients with Various Types of Anemias and Myeloproliferative Disorders

Masato Mitsuhashi, MD PhD, Taku Murakami, PhD, Teodora Kuzmanovic, Cassandra M. Hirsch, BSc, Hideki Makishima, MD, PhD, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 5070.

https://doi.org/10.1182/blood.V128.22.5070.5070

Published: 2016

Journal Articles

Curious Case of Profound Thrombocytopenia in a Pregnant Woman

Prabhsimranjot Singh, MBBS, Makardhwaj S Shrivastava, MBBS, Daniel Benasher, MD, Audrik Perez, MD, Philip Rubin, MD

Blood (2016) 128 (22): 4944.

https://doi.org/10.1182/blood.V128.22.4944.4944

Published: 2016

Journal Articles

A Clinical Measure of DNA Methylation Predicts Outcome in De Novo AML

Marlise R. Luskin, MD, Phyllis Gimotty, PhD, Catherine Smith, Alison Loren, MD MS, Maria Figueroa, MD, Jenna Harrison, Zhuoxin Sun, PhD, Martin S Tallman, MD, Elisabeth Paietta, PhD, Mark R Litzow, MD, Ross L. Levine, MD, Hugo F. Fernandez, MD, Selina Luger, MD, Martin Carroll, MD, Stephen Master, MD PhD, Gerald Wertheim, MD PhD

Blood (2015) 126 (23): 2591.

https://doi.org/10.1182/blood.V126.23.2591.2591

Published: 2015

Journal Articles

The Diagnostic Accuracy of Bleeding Assessment Tools for the Identification of Patients with Mild Bleeding Disorders: A Systematic Review

Floor CJI Moenen, MD, Yvonne MC Henskens, MSc PhD, Saskia AM Schols, MD PhD, Patty J Nelemans, MD PhD, Harry C. Schouten, MD PhD, Erik AM Beckers, MDPhD

Blood (2015) 126 (23): 4473.

https://doi.org/10.1182/blood.V126.23.4473.4473

Published: 2015

Journal Articles

Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

Patrick T. McGann, MD MS, Min Dong, PhD, Russell E. Ware, MD PhD, Alexander A Vinks, PharmD, PhD

Blood (2015) 126 (23): 982.

https://doi.org/10.1182/blood.V126.23.982.982

Published: 2015

NARROW

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Altered Iron Parameters and Hepcidin Levels in a General Population: Lessons from the CHRIS Study

Hepcidin, Soluble Transferrin Receptor, and Other Biomarkers of Iron Status Distributions in Healthy 2 Years Old Infants from a National Ambulatory Study in France

Pathological Hepatic Contrast-Enhanced Ultrasound (CEUS) Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation (allo-SCT)

Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NFkB Activation in Preclinical Patient-Derived Models of CNS Lymphoma

A Novel RAD51 Inhibitor, CYT01B, Shows Anti-Cancer Activity in Preclinical Models of Aid Expressing Lymphomas

Molecular Quantification of Tissue Mast Cell Burden in Systemic Mastocytosis: A New Approach for Diagnostics and Prognostication

New Blood Based M-Protein Quantification Method 3,000 Times More Sensitive Than Standard SPEP

Chronic Hemolysis, Oxidative Stress and Inflammation Contribute to Dysfunctional HDL in Sickle Cell Disease

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study

Phase II, Multiple-Dose Study of Anti-FcRn Antibody, Rozanolixizumab (UCB7665), in Patients with Primary Immune Thrombocytopenia: Interim Analysis

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Evaluating Pembrolizumab Interference with Monoclonal Protein Detection By Immunofixation and By MALDI-TOF Mass Spectrometry (MASS-FIX)

Hemophilia a Clots Generated with Recombinant Factor VIIa Differed in Structure and Composition from Those Formed with Factor VIII

Quantification of Erythroblast- and Myelocyte-Derived mRNAs in Plasma Exosomes As an Indicator of Bone Marrow Status in Patients with Various Types of Anemias and Myeloproliferative Disorders

Curious Case of Profound Thrombocytopenia in a Pregnant Woman

A Clinical Measure of DNA Methylation Predicts Outcome in De Novo AML

The Diagnostic Accuracy of Bleeding Assessment Tools for the Identification of Patients with Mild Bleeding Disorders: A Systematic Review

Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only